Reported 1 day ago
Hologic, Inc., focused on women's health technologies, has seen its stock rise 27.8% from a 52-week low, but it still lags behind the S&P 500, which gained 11.4% in the same period. Over the last year, Hologic's shares dropped 19.5%, while the S&P 500 gained 16.6%. Despite this underperformance, analysts maintain a 'Moderate Buy' rating with a potential upside of 12.1% to $74.38, and some predict a high target of $94, indicating a 41.7% increase.
Source: YAHOO